Lumena Pharmaceuticals Files For IPO

San Diego-based Lumena Pharmaceuticals has filed for an IPO, saying in a filing with the SEC that it is looking to raise up to $75.0M in a public offering. Lumena said that it has applied to list on the NASDAQ Global Market as LIVR. Lumena's IPO is being underwritten by Citigroup, Cowen and Company, and Leerink Partners. Lumena is developing treatments for nonalcoholic steatohepatitis (NASH) and other, cholestatic liver diseases and serious metabolic disorders. The company is venture backed by Alta Partners, New Enterprise Associates, RiverVest, A.M. Pappas Life Sciences Ventures, and Adage Capital Partners.